FDA approves Regeneron, Sanofi $37,000 per year eczema drug

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's drug for moderate-to-severe atopic dermatitis, a product widely seen as the most important future growth driver for the two companies.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news